Hypertension Journal

Register      Login

VOLUME 1 , ISSUE 1 ( July-September, 2015 ) > List of Articles

RESEARCH ARTICLE

Ambulatory Blood Pressure Measurements in the Management of Hypertension: Practical Importance

Pakshirajan Balaji, Ajit Mullasari Sankaradas

Keywords : Ambulatory,Blood pressure monitoring,Hypertension

Citation Information : Balaji P, Mullasari Sankaradas A. Ambulatory Blood Pressure Measurements in the Management of Hypertension: Practical Importance. Hypertens J 2015; 1 (1):13-21.

DOI: 10.5005/jp-journals-10043-0003

Published Online: 00-09-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Pakshirajan B, Ajit MS. Ambulatory Blood Pressure Measurements in the Management of Hypertension: Practical Importance. Hypertens J 2015;1(1): 13-21.


PDF Share
  1. Diabetic and hypertensive heart disease. Ann Intern Med 1996;125(4):304-310.
  2. Ambulatory blood pressure monitoring. MJA 2002;176(12):588-592.
  3. Ambulatory blood pressure and mortality: a population-based study. Hypertens 2005;45(4):499-504.
  4. Blood pressure monitoring. Task force III. Target organ damage, morbidity and mortality. Blood Press Monit 1999;4(6):303-317.
  5. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997;95(6): 1464-1470.
  6. The prognostic value of ambulatory blood pressures. JAMA 1983;249(20):2792-2798.
  7. Prognostic value of ambulatory blood pressure measurements: further analysis. J Hypertens 1989;l7(3):S3-S10.
  8. Prognostic value of ambulatory blood pressure. Current evidence and clinical implications. Hypertens 2000;35(3):844-851.
  9. Prognostic significance of ambulatory blood pressure. Blood Press Monit 1999;4(5):249-256.
  10. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investi-gators. JAMA 1999;282(6):539-546.
  11. Prediction of stroke by ambulatory blood pressure monitoring vs screening blood pressure measurements in a general population: the Ohasama study. J Hypertens 2000;18(7):847-854.
  12. Ambu-latory vs home vs clinic blood pressure: the association with subclinical cerebrovascular diseases: the Ohasama Study. Hypertens 2012;59(1):22-28.
  13. Optimal definition of day time and night time blood pressure. Blood Press Monit 1997;2(6):315-321.
  14. Ambulatory blood pressure measurement: what is the international consensus? Hypertens 2013;62(6):988-994.
  15. Home blood pressure measurement has a stronger predictive power for mortality thandoes screening blood pressure measure-ment: a population-based observation in Ohasama, Japan. J Hypertens 1998;16(7):971-975.
  16. Home blood pressure is as reliable as ambulatory blood pressure in predicting target-organ damage in hypertension. Am J Hypertens 2007;20(6):616-621.
  17. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertens 2010;55(6):1346-1351.
  18. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 2011;342:d3621.
  19. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ 2000;320(7242):1128-1134.
  20. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1996;9(1):1-11.
  21. Canadian Hypertension Society guidelines for ambulatory blood pressure monitoring. Am J Hypertens 1999;12:1149-1157.
  22. The relationship of plasma renin activity to clinic and ambulatory blood pressure in elderly people with isolated systolic hypertension. J Hypertens Suppl 1988;6(4):S412-415.
  23. Abnormalities in ambulatory blood pressure monitoring in hypertensive patients with diabetes. Hypertens Res 2011;34(11):1185-1189.
  24. Differential effects of doxazosin on clinic and ambulatory pressure according to age, gender, and presence of white coat hypertension: results of the HALT Study. Am J Hypertens 1994;7:848-852.
  25. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Circulation 2000;102(10):1139-1144.
  26. Impact of white-coat hypertension onmicrovascular complications in type two diabetes. Diabetes Care 2008;31(12):2233-2237.
  27. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertens 2009;54(2):226-232.
  28. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertens 2012;59(3):564-571.
  29. Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension. J Hypertens 2009;27(8):1672-1678.
  30. Whatisthe relationship between white coat hypertension and dyslipidemia? Int Heart J 2008;49(1):87-93.
  31. Cost-effectiveness of ambulatory blood pressure: a reanalysis. Hypertens 2006;47(1):29-34.
  32. Short-and long-term incidence of stroke in white-coat hypertension. Hypertens 2005;45(2):203-208.
  33. White coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens 1991;4(10 pt 1):844-849.
  34. Is resistant hypertension really resistant? Am J Hypertens 2001;14(12):1263-1269.
  35. Clinical features of 8295 patients with resistant hypertension classi-fied on the basis of ambulatory blood pressure monitoring. Hypertens 2011;57(5):898-902.
  36. Masked hypertension. Hypertens 2002;40(6):795-796.
  37. Ambulatory blood pressure monitoring in type two diabetes and metabolic syndrome: a review. Blood Press Monit 2010;15(1):1-7.
  38. Should 24 hours ambulatory blood pressure monitoring be done in every patient with diabetes? Diabetes Care 2009;32(Suppl 2):S298-S304.
  39. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007; 25(11):2193-2199.
  40. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta-analysis. Am J Hypertens 2011;24(1):52-58.
  41. Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J Hypertens 2012;30(2):253-266.
  42. Association of masked hypertension and left ventricular remodeling with the hypertensive response to exercise. Am J Hypertens 2011;24(8):898-903.
  43. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 2005;18(11):1422-1428.
  44. Prognostic significance of 24 hours ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens 2004;22(9):1691-1697.
  45. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999;131(8):564-572.
  46. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation 2001; 104(12):1385-1392.
  47. Masked hypertension and prehypertension: diagnostic overlap and interrelation-ships with left ventricular mass: the Masked Hypertension Study. Am J Hypertens 2012;25(6):664-671.
  48. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24 hours blood pressure: the Ohasama study. J Hypertens 2002;20(11): 2183-2189.
  49. Ambulatory blood pressure monitoring in normo-tensive and hypertensive type two diabetes. Prevalence of impaired diurnal blood pressure patterns. Am J Hypertens 1993;6(1):1-7.
  50. Arterialhypertension determined by ambulatory blood pressure profiles: contribution to microalbuminuria risk in a multicenter investigation in 2,105 children and adolescents with type one diabetes. Diabetes Care 2008;31(4):720-725.
  51. Orthostatic hypotension is associated with nocturnal change in systolic blood pressure. Am J Hypertens 2012;25(2):159-164.
  52. Abnormal nocturnal blood pressure profile is associated with mild cognitive impairment in the elderly: the J-SHIPP study. Hypertens Res 2010;33(1):32-36.
  53. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 2005;46(1):156-161.
  54. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 2010;28(10): 2036-2045.
  55. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertens 2006;47(2):149-154.
  56. Standards of medical care in diabetes-2013. Diabetes Care 2013;36(suppl 1):S11-S66.
  57. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol 2011;58(11):1165-1173.
  58. Additional impact of morning hemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients. Eur Heart J 2011;32(5):574-580.
  59. Importance of blood pressure control over a 24 hours period. J Manag Care Pharm 2007;13(suppl 8 B):34-39.
  60. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type two diabetes. Diabetes Care 2011;34(6):1270-1276.
  61. Night time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 2005;23(3): 521-527.
  62. J Clin Epidemiol 2009;62(7):745-751.
  63. Micro albuminuria and hypertension. Minerva Med 2005;96(4):261-275.
  64. Arterial distensibility and ambulatory blood pressure monitoring in essential hypertension. Am J Cardiol 1988;61(13): 1066-1070.
  65. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation 2002 Nov 5;106(19):2422-2427.
  66. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy? J Hum Hypertens 2004;18(suppl 2):S23-S28.
  67. Prognostic accuracy of day vs night ambulatory blood pressure: a cohort study. Lancet 2007;370(9594):1219-1229.
  68. Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertens 1997;29(1):22-29.
  69. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertens 2012;60(1):34-42.
  70. Prognostic value of circadian blood pressure changes in relation to differing measures of day and night. J Am Soc Hypertens 2008;2(2):88-96.
  71. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertens 2007;49(6):1265-1270.
  72. Impact of blood pressure variability on cardiac and cerebro-vascular complications in hypertension. Am J Hypertens 2007;20(2):154-161.
  73. Different prognostic impact of 24-hours mean blood pressure and pulse pressure on stroke and coronary artery disease in essential hypertension. Circulation 2001;103(21):2579-2584.
  74. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 1987;60(10):801-806.
  75. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313(21):1315-1322.
  76. Prognostic value of the morning blood pressure surge in 5645 subjects from eight populations. Hypertens 2010;55(4): 1040-1048.
  77. Blunted heart rate dip during sleep and all-cause mortality. Arch Intern Med 2007;167(19):2116-2121.
  78. Prognostic value of ambulatory heart rate revisited in 6928 subjects from six populations. Hypertens 2008;52(2):229-235.
  79. Ambulatory blood pressure monitoring. Med J Aust 2002;176(12):588-592.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.